279 related articles for article (PubMed ID: 23451184)
1. Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.
Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Rodella S; Zoppini G; Mantovani W; Barbieri E; Byrne CD
PLoS One; 2013; 8(2):e57183. PubMed ID: 23451184
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes.
Targher G; Mantovani A; Pichiri I; Rigolon R; Dauriz M; Zoppini G; Morani G; Vassanelli C; Bonora E
Clin Sci (Lond); 2013 Sep; 125(6):301-9. PubMed ID: 23596966
[TBL] [Abstract][Full Text] [Related]
3. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus.
Valbusa F; Bertolini L; Bonapace S; Zenari L; Zoppini G; Arcaro G; Byrne CD; Targher G
Am J Cardiol; 2013 Aug; 112(4):499-504. PubMed ID: 23672990
[TBL] [Abstract][Full Text] [Related]
4. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
[TBL] [Abstract][Full Text] [Related]
5. Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis.
Mantovani A; Dauriz M; Sandri D; Bonapace S; Zoppini G; Tilg H; Byrne CD; Targher G
Liver Int; 2019 Apr; 39(4):758-769. PubMed ID: 30657626
[TBL] [Abstract][Full Text] [Related]
6. Early impairment in left ventricular longitudinal systolic function is associated with an increased risk of incident atrial fibrillation in patients with type 2 diabetes.
Bonapace S; Valbusa F; Bertolini L; Zenari L; Canali G; Molon G; Lanzoni L; Cecchetto A; Rossi A; Mantovani A; Zoppini G; Barbieri E; Targher G
J Diabetes Complications; 2017 Feb; 31(2):413-418. PubMed ID: 27884663
[TBL] [Abstract][Full Text] [Related]
7. The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.
Käräjämäki AJ; Hukkanen J; Ukkola O
Ann Med; 2018 Aug; 50(5):371-380. PubMed ID: 29929399
[TBL] [Abstract][Full Text] [Related]
8. Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation.
Mahfouz RA; Gouda M; Galal I; Ghareb MS
Echocardiography; 2019 Feb; 36(2):249-256. PubMed ID: 30548700
[TBL] [Abstract][Full Text] [Related]
9. Increased pulse pressure independently predicts incident atrial fibrillation in patients with type 2 diabetes.
Valbusa F; Bonapace S; Bertolini L; Zenari L; Arcaro G; Targher G
Diabetes Care; 2012 Nov; 35(11):2337-9. PubMed ID: 22837366
[TBL] [Abstract][Full Text] [Related]
10. Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).
Käräjämäki AJ; Pätsi OP; Savolainen M; Kesäniemi YA; Huikuri H; Ukkola O
PLoS One; 2015; 10(11):e0142937. PubMed ID: 26571029
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up.
Zelber-Sagi S; Lotan R; Shibolet O; Webb M; Buch A; Nitzan-Kaluski D; Halpern Z; Santo E; Oren R
Liver Int; 2013 Oct; 33(9):1406-12. PubMed ID: 23656177
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus.
Bonapace S; Valbusa F; Bertolini L; Pichiri I; Mantovani A; Rossi A; Zenari L; Barbieri E; Targher G
PLoS One; 2014; 9(2):e88371. PubMed ID: 24505484
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals.
Mantovani A; Zoppini G; Targher G; Golia G; Bonora E
J Endocrinol Invest; 2012 Feb; 35(2):215-8. PubMed ID: 22490991
[TBL] [Abstract][Full Text] [Related]
14. Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Kang MK; Park JG; Kim MC
Yonsei Med J; 2020 Oct; 61(10):860-867. PubMed ID: 32975060
[TBL] [Abstract][Full Text] [Related]
15. Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP).
Markus MR; Meffert PJ; Baumeister SE; Lieb W; Siewert U; Schipf S; Koch M; Kors JA; Felix SB; Dörr M; Targher G; Völzke H
Atherosclerosis; 2016 Feb; 245():123-31. PubMed ID: 26722832
[TBL] [Abstract][Full Text] [Related]
16. Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults.
Roh JH; Lee JH; Lee H; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Liver Int; 2020 Feb; 40(2):338-346. PubMed ID: 31479572
[TBL] [Abstract][Full Text] [Related]
17. Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.
Long MT; Yin X; Larson MG; Ellinor PT; Lubitz SA; McManus DD; Magnani JW; Staerk L; Ko D; Helm RH; Hoffmann U; Chung RT; Benjamin EJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28465298
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease is associated with increased risk of atrial fibrillation.
Cai X; Zheng S; Liu Y; Zhang Y; Lu J; Huang Y
Liver Int; 2020 Jul; 40(7):1594-1600. PubMed ID: 32279432
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study.
Choi JH; Rhee EJ; Bae JC; Park SE; Park CY; Cho YK; Oh KW; Park SW; Lee WY
Arch Med Res; 2013 Feb; 44(2):115-20. PubMed ID: 23398788
[TBL] [Abstract][Full Text] [Related]
20. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population.
Chang Y; Jung HS; Yun KE; Cho J; Cho YK; Ryu S
Am J Gastroenterol; 2013 Dec; 108(12):1861-8. PubMed ID: 24100261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
